Search Within

Barbara Spitzer

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (20)
  2. Meeting Abstract (12)
  3. Research Letter (1)
Groups
  1. Department of Medicine (33)
  2. Epidemiology and Biostatistics (33)
  3. GSK Faculty (33)
  4. Pediatrics, Department of (33)
  5. Stem Cell Transplantation and Cellular Therapy Service (33)
  6. Tow Center for Developmental Oncology (TCDO) (29)

More Groups

People
  1. Ross Levine (15)
  2. Kevin Curran (13)
  3. Nancy Kernan (13)
  4. Richard O'Reilly (13)
  5. Farid Boulad (12)
  6. Jaap Jan Boelens (12)

More People

Years
  1. 2024 (4)
  2. 2023 (5)
  3. 2022 (5)
  4. 2021 (3)
  5. 2020 (8)
  6. 2019 (3)

More Years

Publications
  1. Blood (6)
  2. Blood Advances (5)
  3. Bone Marrow Transplantation (3)
  4. Clinical Cancer Research (2)
  5. Journal of Clinical Oncology (2)
  6. Nature Communications (2)

More Publications

Publishers
  1. American Society of Hematology (11)
  2. Nature Publishing Group (9)
  3. American Association for Cancer Research (4)
  4. American Society of Clinical Oncology (2)
  5. Elsevier Inc. (2)
  6. American Society for Clinical Investigation (1)

More Publishers

Results (33)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Rabbit anti-thymocyte globulin (ATG) exposure after ex vivo T-cell-depleted hematopoietic cell transplantation is variable and impacts immune reconstitution and survival in children and young adults
    Meeting Abstract

    Lakkaraja, M.; Mauguen, A.; Boulad, F.; Spitzer, B.; Scaradavou, A.; Curran, K.; Cancio, M.; Roessel, I.; Klein, E.; Kernan, N.; more...
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Cancer therapy shapes the fitness landscape of clonal hematopoiesis
    Journal Article

    Bolton, K. L.; Ptashkin, R. N.; Gao, T.; Braunstein, L.; Devlin, S. M.; Kelly, D.; Patel, M.; Berthon, A.; Syed, A.; Yabe, M.; more...
    Nature Genetics (2020)

    Fulltext@MSK | Save
  • Low toxicity and favorable overall survival in relapsed/refractory B-ALL following CAR T cells and CD34-selected T-cell depleted allogeneic hematopoietic cell transplant
    Journal Article

    Fabrizio, V. A.; Kernan, N. A.; Boulad, F.; Cancio, M.; Allen, J.; Higman, M.; Margossian, S. P.; Mauguen, A.; Prockop, S.; Scaradavou, A.; more...
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Rabbit anti-thymocyte globulin (ATG) exposure after ex vivo T-cell depleted hematopoietic cell transplantation is highly variable and impacts immune reconstitution in pediatric and young adult patients
    Meeting Abstract

    Lakkaraja, M.; Mauguen, A.; Boulad, F.; Spitzer, B.; Scaradavou, A.; Curran, K. J.; Cancio, M.; van Roessel, I.; Kernan, N. A.; O'Reilly, R. J.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation
    Journal Article

    Prockop, S.; Doubrovina, E.; Suser, S.; Heller, G.; Barker, J.; Dahi, P.; Perales, M. A.; Papadopoulos, E.; Sauter, C.; Castro-Malaspina, H.; more...
    Journal of Clinical Investigation (2020)

    Fulltext@MSK | Save
  • Allogeneic CD34-selected HSCT following CAR T-cells is associated with low TRM and favorable OS in pediatric/young adult patients with relapsed/refractory B-ALL
    Meeting Abstract

    Fabrizio, V.; Boulad, F.; Cancio, M. I.; Higman, M. A.; Margossian, S. P.; Mauguen, A.; Prockop, S.; Scaradavou, A.; Shah, N. C.; Spitzer, B.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL
    Journal Article

    Curran, K. J.; Margossian, S. P.; Kernan, N. A.; Silverman, L. B.; Williams, D. A.; Shukla, N.; Kobos, R.; Forlenza, C. J.; Steinherz, P.; Prockop, S.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • CAR T-cells followed by CD34-selected T-cell depleted (TCD) ALLO-HSCT is associated with low toxicity and favorable overall survival
    Meeting Abstract

    Fabrizio, V.; Boulad, F.; Cancio, M.; Margossian, S.; Mauguen, A.; Prockop, S.; Scaradavou, M.; Shah, N.; Spitzer, B.; Stieglitz, E.; more...
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Early detection and molecular characterization of therapy-related leukemia in children reveals patterns of disease transformation and guides future surveillance protocols
    Meeting Abstract

    Spitzer, B.; Gundem, G.; Farnoud, N.; Millard, N.; McGovern, E.; Patel, M.; Levine, M.; Medina, J.; Zhou, Y.; Arango Ossa, J. E.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia
    Journal Article

    Brown, F. C.; Still, E.; Koche, R. P.; Yim, C. Y.; Takao, S.; Cifani, P.; Reed, C.; Gunasekera, S.; Ficarro, S. B.; Romanienko, P.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save